Archive for October, 2004

Biotech execs have a sense of humor about elusive profits

Biotech execs have a sense of humor about elusive profits When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.


Foresight or folly? Generics firms' foray into NCEs

Foresight or folly? Generics firms’ foray into NCEs A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into […]